Skip navigation
Search
Search
Cancer and Therapeutics Online at Queen Mary University of London - UCAS

Course options

2023 - 20242024 - 2025
Apply

There are other course options available which may have a different vacancy status or entry requirements – view the full list of options

Course summary

This programme gives you the foundation in molecular and cellular biology that is fundamental to cancer biology and research. You’ll study and contribute to the latest developments in curing cancer, such as novel drugs and gene therapy. You’ll also discover how new therapies are developed, evaluated and implemented.

  • Taught by the UK’s leading oncology experts – we’re ranked number one for cancer research (REF 2014)
  • Part-time programme option, so you can fit your studies around your other commitments
  • Gives you a solid background in cancer therapy but then allows you to specialise
  • An ideal career boost: discover how to develop and implement new treatments
This programme gives you a thorough grounding in the scientific principles underlying cancer treatment. You’ll discover how new treatments are developed, evaluated and implemented. By the end of the course, you’ll be equipped with a thorough knowledge of cancer biology and pathology, research methodologies, drug development, and regulatory issues. You’ll have a firm grounding in the use and evaluation of cancer therapies, which will enhance your career prospects in many areas of cancer research, early phase clinical trials, This programme is delivered by the Barts Cancer Institute, a Cancer Research UK centre of excellence and part of the Cancer Research UK City of London Centre. As a distance-learning student, you’ll be taught via our online platform, QMplus. You’ll have access to recorded lectures, copies of the slides and other supporting materials. We encourage you to interact with staff and students in our online forums, join group activities and become part of our student community. Dissertations will be supervised by a Barts Cancer Institute (BCI) researcher and supervision meetings will be conducted by telephone or by Skype. Undertaking a masters programme is a commitment and you’ll be expected to spend time studying independently in addition to your contact hours. If you study part-time, the modules you’ll need to complete the programme will be spread over two years.

Modules

Please see website for up-to-date module information

Assessment method

Posters and oral presentations will be delivered via Skype. Examinations can be at Queen Mary University of London or at an approved local venue (usually a British Council or a local academic institution).

Entry requirements

Degree requirements A 2:1 or above at undergraduate level in a relevant subject such as Biology, Chemistry, Pharmacology, Medicine from a recognised academic institution. Applicants with a 2:2 degree will be considered on an individual basis. Other routes The programme is open to graduate scientists, clinicians and other medical professionals working in healthcare, the pharmaceutical industry or contract research organisations.

Fees and funding

Tuition fees

No fee information has been provided for this course

Additional fee information

Students enrolling on a postgraduate degree programme are charged tuition fees each year by Queen Mary. The rate you will be charged depends on whether you are assessed as a Home/EU or Overseas student. You can find tuition fees for each course on the course finder pages on our website: https://www.qmul.ac.uk/postgraduate/ Further details about postgraduate taught tuition fees can also be found on our website: https://www.qmul.ac.uk/postgraduate/taught/tuitionfees/
Cancer and Therapeutics Online at Queen Mary University of London - UCAS